• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
Medicare Part B to Cover New CLIA-Waived Tests on Oct. 1

Medicare Part B to Cover New CLIA-Waived Tests on Oct. 1

by Glenn S. Demby | Sep 12, 2022 | News, Open Content

Make sure your lab billing staff is aware of the changes to ensure full reimbursement.

First Diagnostic Test for Long COVID Receives CE-IVD Marking

First Diagnostic Test for Long COVID Receives CE-IVD Marking

by Rachel Muenz | Aug 31, 2022 | News, Open Content

Based on validation study data, the test offers 90 percent accuracy and is unaffected by the emergence of new COVID-19 variants.

New Patient Guidelines Released for Breast Cancer Screening and Diagnosis

New Patient Guidelines Released for Breast Cancer Screening and Diagnosis

by Rachel Muenz | Aug 31, 2022 | News, Open Content

The new guidelines offer patients advice on when they should start their screening, and how often they should have it done.

New Guidelines Recommend Molecular Testing for Pediatric Brain Cancer Treatment

New Guidelines Recommend Molecular Testing for Pediatric Brain Cancer Treatment

by Glenn S. Demby | Aug 26, 2022 | News, Open Content, Special Focus-dtet

For labs, the big takeaway is how prominently molecular testing and profiling figures in so many aspects of the NCCN’s recommendations.

CDC, Major Laboratory Companies Launch New Tests for Monkeypox

CDC, Major Laboratory Companies Launch New Tests for Monkeypox

by Glenn S. Demby | Jul 19, 2022 | News, Open Content

As the outbreak continues to grow in countries that have not historically seen monkeypox cases, testing companies are stepping up.

Next Entries »

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com